{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "currency": "EUR", "market": "dr_market", "esgPopulated": false, "gmtOffSetMilliseconds": 7200000, "exchange": "FRA", "longName": "Vyant Bio, Inc.", "shortName": "VYANT BIO INC.NEW  -,0001", "regularMarketPrice": 0.298, "regularMarketChangePercent": -8.02469, "messageBoardId": "finmb_317919842", "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.93521744, "fiftyTwoWeekLow": 0.242, "fiftyTwoWeekHigh": 4.6, "earningsTimestamp": 1680292800, "earningsTimestampStart": 1684153800, "earningsTimestampEnd": 1684499400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "fiftyTwoWeekLowChange": 0.05600001, "fiftyTwoWeekLowChangePercent": 0.231405, "fiftyTwoWeekRange": "0.242 - 4.6", "fiftyTwoWeekHighChange": -4.302, "epsTrailingTwelveMonths": -2.42, "sharesOutstanding": 6267710, "bookValue": 1.673, "fiftyDayAverage": 0.51804, "fiftyDayAverageChange": -0.22004, "fiftyDayAverageChangePercent": -0.42475483, "twoHundredDayAverage": 1.630912, "twoHundredDayAverageChange": -1.332912, "twoHundredDayAverageChangePercent": -0.8172802, "marketCap": 1985150, "priceToBook": 0.17812315, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1619157600000, "priceHint": 4, "regularMarketChange": -0.025999993, "regularMarketTime": 1683871215, "regularMarketDayHigh": 0.298, "regularMarketDayRange": "0.298 - 0.298", "regularMarketDayLow": 0.298, "regularMarketVolume": 99, "regularMarketPreviousClose": 0.324, "bid": 0.258, "ask": 0.288, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 0.298, "averageDailyVolume3Month": 8, "averageDailyVolume10Day": 9, "symbol": "1C80.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2 Executive Campus", "address2": "2370 State Route 70 Suite 310", "city": "Cherry Hill", "state": "NJ", "zip": "08002", "country": "United States", "phone": "201 479 1357", "website": "https://www.vyantbio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). The company is based in Cherry Hill, New Jersey.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. Andrew D.C. LaFrence CPA, CPA", "age": 59, "title": "Pres, CEO & CFO", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 407400, "fmt": "407.4k", "longFmt": "407,400"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Yung-Ping  Yeh M.B.A., M.S., P.M.P.", "age": 46, "title": "Co-Founder & Director", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": {"raw": 22500, "fmt": "22.5k", "longFmt": "22,500"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}